Bodyharm MOTS-C 10mg Vial

Body Pharm MOTS-C 10mg is a research-grade lyophilised vial of the 16-amino-acid mitochondrial-derived peptide MRWQEMGYIFYPRKLR, supplied for in vitro and preclinical investigation of insulin sensitivity and exercise physiology by South African laboratories. This overview consolidates the biochemical profile, the 2024–2026 evidence base, and the local regulatory and sourcing context that South African researchers need before procurement.

Key Takeaways

• MOTS-C is a 16-residue mitochondrial-derived peptide encoded in mtDNA (not nuclear DNA), making it mechanistically distinct from nuclear-encoded growth peptides
• No Phase III human trial has reported; evidence remains dominated by rodent models and human biomarker associations
• Body Pharm MOTS-C 10mg is supplied for laboratory research only and is not registered with SAHPRA as a medicine
• Storage at −20 °C or colder maintains stability for 12+ months; reconstituted material should be aliquoted and refrozen to avoid degradation
• Open-web searches return no R-denominated listing on South African retailers as of 2026; international equivalents cost roughly USD 65–USD 110 per vial
• Procurement for human use contravenes SAHPRA policy; laboratory-only use under institutional licence is the permitted pathway